Filling out the Hippo pathway

Nature Reviews Molecular Cell Biology

Volumn 8, Issue 8, 2007, Pages 613-621

  Saucedo, Leslie J ^a,b   Edgar, Bruce A ^b  

^a UNIVERSITY OF PUGET SOUND   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BANTAM; BONE MORPHOGENETIC PROTEIN 4; CADHERIN; CYCLIN E; DROSOPHILA INHIBITOR OF APOPTOSIS 1; EPIDERMAL GROWTH FACTOR RECEPTOR; FAT PROTEIN; FERM DOMAIN CONTAINING 6; LONG ACTING THYROID STIMULATOR; MAMMALIAN STERILE 20 LIKE KINASE TYPE 1; MAMMALIAN STERILE 20 LIKE KINASE TYPE 2; MEMBRANE PROTEIN; MICRORNA; MPS ONE BINDER KIA\NASE ACTIVATOR 1; NEUROFIBROMATOSIS TYPE 2 PROTEIN; PROTEIN; PROTEIN EX; PROTEIN HIPPO; PROTEIN P53; PROTEIN WTS; PROTEIN WW45; RIBOSOMAL PROTEIN L36; RIBOSOME PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT PROTEIN; YES ACTIVATED PROTEIN;

APOPTOSIS; BREAST TUMOR; CARCINOGENESIS; CELL ADHESION; CELL DIFFERENTIATION; DROSOPHILA MELANOGASTER; EPITHELIUM CELL; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; IMMUNOPRECIPITATION; KIDNEY CANCER; MOUSE STRAIN; NONHUMAN; ONCOGENE MYC; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; SARCOMA; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; EPITHELIAL CELLS; HUMANS; MOSAICISM; NEOPLASMS; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

DROSOPHILA MELANOGASTER; MAMMALIA;

EID: 34547124044     PISSN: 14710072     EISSN: 14710080     Source Type: Journal    
DOI: 10.1038/nrm2221     Document Type: Review

References (94)

1. Xu, T. & Rubin, G. M. Analysis of genetic mosaics in developing and adult Drosophila tissues. Development 117, 1223-1237 (1993).
2. Potter, C. J., Turenchalk, G. S. & Xu, T. Drosophila in cancer research. An expanding role. Trends Genet. 16, 33-39 (2000).
3. McClatchey, A. I. & Giovannini, M. Membrane organization and tumorigenesis - the NF2 tumor suppressor, Merlin. Genes Dev. 19, 2265-2277 (2005).
4. Overholtzer, M. et al. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc. Natl Acad. Sci. USA 103, 12405-12410 (2006).
5. Zender, L. et al. Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 125, 1253-1267 (2006).
6. Edgar, B. A. From cell structure to transcription: Hippo forges a new path. Cell 124, 267-273 (2006).
7. Pan, D. Hippo signaling in organ size control. Genes Dev. 21, 886-897 (2007).
8. Harvey, K. & Tapon, N. The Salvador-Warts-Hippo pathway - an emerging tumour-suppressor network. Nature Rev. Cancer 7, 182-191 (2007).
9. Justice, R. W., Zilian, O., Woods, D. F., Noll, M. & Bryant, P. J. The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev. 9, 534-546 (1995).
10. Xu, T. A., Wang, W. Y., Zhang, S., Stewart, R. A. & Yu, W. Identifying tumor suppressors in genetic mosaics - the Drosophila lats gene encodes a putative protein-kinase. Development 121, 1053-1063 (1995).
11. Harvey, K. F., Pfleger, C. M. & Hariharan, I. K. The Drosophila Mst ortholog, hippo, restricts growth and cell proliferation and promotes apoptosis. Cell 114, 457-467 (2003).
12. Kango-Singh, M. et al. Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila. Development 129, 5719-5730 (2002).
13. Pantalacci, S., Tapon, N. & Leopold, P. The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila. Nature Cell Biol. 5, 921-927 (2003).
14. Tapon, N. et al. salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell 110, 467-478 (2002).
15. Udan, R. S., Kango-Singh, M., Nolo, R., Tao, C. & Halder, G. Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway. Nature Cell Biol. 5, 914-920 (2003).
16. Wu, S., Huang, J., Dong, J. & Pan, D. hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell 114, 445-456 (2003).
17. Lai, Z. C. et al. Control of cell proliferation and apoptosis by mob as tumor suppressor, mats. Cell 120, 675-685 (2005).
18. Wei, X., Shimizu, T. & Lai, Z. C. Mob as tumor suppressor is activated by Hippo kinase for growth inhibition in Drosophila. EMBO J. 26, 1772-1781 (2007).
19. Chan, E. H. et al. The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1. Oncogene 24, 2076-2086 (2005).
20. Hergovich, A., Schmitz, D. & Hemmings, B. A. The human tumour suppressor LATS1 is activated by human MOB1 at the membrane. Biochem. Biophys. Res. Commun. 345, 50-58 (2006).
21. Callus, B. A., Verhagen, A. M. & Vaux, D. L. Association of mammalian sterile twenty kinases, Mst1 and Mst2, with hSalvador via C-terminal coiled-coil domains, leads to its stabilization and phosphorylation. FEBS J. 273, 4264-4276 (2006).
22. Huang, J., Wu, S., Barrera, J., Matthews, K. & Pan, D. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP. Cell 122, 421-434 (2005).
23. Strano, S. et al. The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA damage. Mol. Cell 18, 447-459 (2005).
24. Howell, M., Borchers, C. & Milgram, S. L. Heterogeneous nuclear ribonuclear protein U associates with YAP and regulates its co-activation of Bax transcription. J. Biol. Chem. 279, 26300-26306 (2004).
25. Zaidi, S. K. et al. Tyrosine phosphorylation controls Runx2-mediated subnuclear targeting of YAP to repress transcription. EMBO J. 23, 790-799 (2004).
26. Komuro, A., Nagai, M., Navin, N. E. & Sudol, M. WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus. J. Biol. Chem. 278, 33334-33341 (2003).
27. Ferrigno, O. et al. Yes-associated protein (YAP65) interacts with Smad7 and potentiates its inhibitory activity against TGF-β/Smad signaling. Oncogene 21, 4879-4884 (2002).
28. Espanel, X. & Sudol, M. Yes-associated protein and p53-binding protein-2 interact through their WW and SH3 domains. J. Biol. Chem. 276, 14514-14523 (2001).
29. Yagi, R., Chen, L. F., Shigesada, K., Murakami, Y. & Ito, Y. A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator. EMBO J. 18, 2551-2562 (1999).
30. Levy, D., Adamovich, Y., Reuven, N. & Shaul, Y. The Yes-associated protein 1 stabilizes p73 by preventing Itch-mediated ubiquitination of p73. Cell Death Differ. 14, 743-751 (2007).
31. Guo, J. et al. Yes-associated protein (YAP65) in relation to Smad7 expression in human pancreatic ductal adenocarcinoma. Int. J. Mol. Med. 17, 761-767 (2006).
32. Vassilev, A., Kaneko, K. J., Shu, H., Zhao, Y. & DePamphilis, M. L. TEAD/TEF transcription factors utilize the activation domain of YAP65, a Src/Yes-associated protein localized in the cytoplasm. Genes Dev. 15, 1229-1241 (2001).
33. Basu, S., Totty, N. F., Irwin, M. S., Sudol, M. & Downward, J. Akt phosphorylates the Yes-associated protein, YAP, to induce interaction with 14-3-3 and attenuation of p73-mediated apoptosis. Mol. Cell 11, 11-23 (2003).
34. Strano, S. et al. Physical interaction with Yes-associated protein enhances p73 transcriptional activity. J. Biol. Chem. 276, 15164-15173 (2001).
35. Bretscher, A., Edwards, K. & Fehon, R. G. ERM proteins and merlin: integrators at the cell cortex. Nature Rev. Mol. Cell Biol. 3, 586-599 (2002).
36. Boedigheimer, M. & Laughon, A. expanded: a gene involved in the control of cell proliferation in imaginal discs. Development 118, 1291-1301 (1993).
37. Boedigheimer, M. J., Nguyen, K. P. & Bryant, P. J. expanded functions in the apical cell domain to regulate the growth rate of imaginal discs. Dev. Genet. 20, 103-110 (1997).
38. McCartney, B. M., Kulikauskas, R. M., LaJeunesse, D. R. & Fehon, R. G. The neurofibromatosis-2 homologue, Merlin, and the tumor suppressor expanded function together in Drosophila to regulate cell proliferation and differentiation. Development 127, 1315-1324 (2000).
39. Hamaratoglu, F. et al. The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis. Nature Cell Biol. 8, 27-36 (2006).
40. Pellock, B. J., Buff, E., White, K. & Hariharan, I. K. The Drosophila tumor suppressors Expanded and Merlin differentially regulate cell cycle exit, apoptosis, and Wingless signaling. Dev. Biol. 304, 102-115 (2007).
41. Okada, T., Lopez-Lago, M. & Giancotti, F. G. Merlin/ NF-2 mediates contact inhibition of growth by suppressing recruitment of Rac to the plasma membrane. J. Cell Biol. 171, 361-371 (2005).
42. Shaw, R. J. et al. The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling. Dev. Cell 1, 63-72 (2001).
43. Lallemand, D., Curto, M., Saotome, I., Giovannini, M. & McClatchey, A. I. NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions. Genes Dev. 17, 1090-1100 (2003).
44. McPherson, J. P. et al. Lats2/Kpm is required for embryonic development, proliferation control and genomic integrity. EMBO J. 23, 3677-3688 (2004).
45. Neufeld, T. P., de la Cruz, A. F., Johnston, L. A. & Edgar, B. A. Coordination of growth and cell division in the Drosophila wing. Cell 93, 1183-1193 (1998).
46. Buttitta, L. A double-assurance mechanism controls cell cycle exit at differentiation in Drosophila. Dev. Cell 12, 631-643 (2007).
47. Yang, X., Li, D. M., Chen, W. & Xu, T. Human homologue of Drosophila lats, LATS1, negatively regulate growth by inducing G(2)/M arrest or apoptosis. Oncogene 20, 6516-6523 (2001).
48. Xia, H. et al. LATS1 tumor suppressor regulates G2/M transition and apoptosis. Oncogene 21, 1233-1241 (2002).
49. Li, Y. et al. Lats2, a putative tumor suppressor, inhibits G1/S transition. Oncogene 22, 4398-4405 (2003).
50. Lee, K. K., Ohyama, T., Yajima, N., Tsubuki, S. & Yonehara, S. MST, a physiological caspase substrate, highly sensitizes apoptosis both upstream and downstream of caspase activation. J. Biol. Chem. 276, 19276-19285 (2001).
51. Avruch, J., Praskova, M., Ortiz-Vega, S., Liu, M. & Zhang, X. F. Nore1 and RASSF1 regulation of cell proliferation and of the MST1/2 kinases. Methods Enzymol. 407, 290-310 (2005).
52. Praskova, M., Khoklatchev, A., Ortiz-Vega, S. & Avruch, J. Regulation of the MST1 kinase by autophosphorylation, by the growth inhibitory proteins, RASSF1 and NORE1, and by Ras. Biochem. J. 381, 453-462 (2004).
53. Guo, C. et al. RASSF1A is part of a complex similar to the Drosophila Hippo/Salvador/Lats tumor-suppressor network. Curr. Biol. 17, 700-705 (2007).
54. Bryant, P. J., Huettner, B., Held, L. I. Jr, Ryerse, J. & Szidonya, J. Mutations at the fat locus interfere with cell proliferation control and epithelial morphogenesis in Drosophila. Dev. Biol. 129, 541-554 (1988).
55. Mahoney, P. A. et al. The fat tumor suppressor gene in Drosophila encodes a novel member of the cadherin gene superfamily. Cell 67, 853-868 (1991).
56. Matakatsu, H. & Blair, S. S. Interactions between Fat and Dachsous and the regulation of planar cell polarity in the Drosophila wing. Development 131, 3785-3794 (2004).
57. Hong, J. C. et al. Identification of new human cadherin genes using a combination of protein motif search and gene finding methods. J. Mol. Biol. 337, 307-317 (2004).
58. Ma, D., Yang, C. H., McNeill, H., Simon, M. A. & Axelrod, J. D. Fidelity in planar cell polarity signalling. Nature 421, 543-547 (2003).
59. Cho, E. & Irvine, K. D. Action of fat, four-jointed, dachsous and dachs in distal-to-proximal wing signaling. Development 131, 4489-4500 (2004).
60. Jaiswal, M., Agrawal, N. & Sinha, P. Fat and Wingless signaling oppositely regulate epithelial cell-cell adhesion and distal wing development in Drosophila. Development 133, 925-935 (2006).
61. Strutt, H. & Strutt, D. Long-range coordination of planar polarity in Drosophila. Bioessays 27, 1218-1227 (2005).
62. Bennett, F. C. & Harvey, K. F. Fat cadherin modulates organ size in Drosophila via the Salvador/Warts/ Hippo signaling pathway. Curr. Biol. 16, 2101-2110 (2006).
63. Cho, E. et al. Delineation of a Fat tumor suppressor pathway. Nature Genet. 38, 1142-1150 (2006).
64. Silva, E., Tsatskis, Y., Gardano, L., Tapon, N. & McNeill, H. The tumor-suppressor gene fat controls tissue growth upstream of expanded in the hippo signaling pathway. Curr. Biol. 16, 2081-2089 (2006).
65. Willecke, M. et al. The fat cadherin acts through the hippo tumor-suppressor pathway to regulate tissue size. Curr. Biol. 16, 2090-2100 (2006).
66. Tyler, D. M. & Baker, N. E. Expanded and fat regulate growth and differentiation in the Drosophila eye through multiple signaling pathways. Dev. Biol. 305, 187-201 (2007). References 62-66 all report independent findings that provide a considerable amount of biochemical and genetic data to position the Hippo pathway as the general mediator of Fat signalling in growth control.
67. Formstecher, E. et al. Protein interaction mapping: a Drosophila case study. Genome Res. 15, 376-384 (2005).
68. Mao, Y. et al. Dachs: an unconventional myosin that functions downstream of Fat to regulate growth, affinity and gene expression in Drosophila. Development 133, 2539-2551 (2006).
69. Nolo, R., Morrison, C. M., Tao, C., Zhang, X. & Halder, G. The bantam microRNA is a target of the hippo tumor-suppressor pathway. Curr. Biol. 16, 1895-1904 (2006).
70. Thompson, B. J. & Cohen, S. M. The Hippo pathway regulates the bantam microRNA to control cell proliferation and apoptosis in Drosophila. Cell 126, 767-774 (2006). References 69 and 70 demonstrate that activation of Yki (normally inhibited by Hippo signalling) leads to the transcriptional induction of bantam, a microRNA that has the ability to promote tissue growth and inhibit apoptosis.
71. Hipfner, D. R., Weigmann, K. & Cohen, S. M. The bantam gene regulates Drosophila growth. Genetics 161, 1527-1537 (2002).
72. Brennecke, J., Hipfner, D. R., Stark, A., Russell, R. B. & Cohen, S. M. bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113, 25-36 (2003).
73. Matakatsu, H. & Blair, S. S. Separating the adhesive and signaling functions of the Fat and Dachsous protocadherins. Development 133, 2315-2324 (2006).
74. Maitra, S., Kulikauskas, R. M., Gavilan, H. & Fehon, R. G. The tumor suppressors Merlin and Expanded function cooperatively to modulate receptor endocytosis and signaling. Curr. Biol. 16, 702-709 (2006).
75. Garoia, F. et al. The tumor suppressor gene fat modulates the EGFR-mediated proliferation control in the imaginal tissues of Drosophila melanogaster. Mech. Dev. 122, 175-187 (2005).
76. Yang, L. & Baker, N. E. Cell cycle withdrawal, progression, and cell survival regulation by EGFR and its effectors in the differentiating Drosophila eye. Dev. Cell 4, 359-369 (2003).
77. O'Neill, E. & Kolch, W. Taming the Hippo: Raf-1 controls apoptosis by suppressing MST2/Hippo. Cell Cycle 4, 365-367 (2005).
78. Colombani, J., Polesello, C., Josue, F. & Tapon, N. Dmp53 activates the Hippo pathway to promote cell death in response to DNA damage. Curr. Biol. 16, 1453-1458 (2006).
79. Polesello, C., Huelsmann, S., Brown, N. H. & Tapon, N. The Drosophila RASSF homolog antagonizes the hippo pathway. Curr. Biol. 16, 2459-2465 (2006).
80. Morata, G. & Ripoll, P. Minutes: mutants of Drosophila autonomously affecting cell division rate. Dev. Biol. 42, 211-221 (1975).
81. Lambertsson, A. The minute genes in Drosophila and their molecular functions. Adv. Genet. 38, 69-134 (1998).
82. de la Cova, C., Abril, M., Bellosta, P., Gallant, P. & Johnston, L. A. Drosophila myc regulates organ size by inducing cell competition. Cell 117, 107-116 (2004).
83. Moreno, E. & Basler, K. dMyc transforms cells into super-competitors. Cell 117, 117-129 (2004).
84. Tyler, D., Li, W., Zhuo, N., Pellock, B. J. & Baker, N. E. Genes affecting cell competition in Drosophila melanogaster. Genetics 175, 643-657 (2006). Shows that mutations in components of the Hippo pathway enable cells to outcompete and eliminate wild-type neighbouring cells. However, the mechanisms that underlie this phenotype remain unclear.
85. Grewal, S. S., Li, L., Orian, A., Eisenman, R. N. & Edgar, B. A. Myc-dependent regulation of ribosomal RNA synthesis during Drosophila development. Nature Cell Biol. 7, 295-302 (2005).
86. Oskarsson, T. & Trumpp, A. The Myc trilogy: lord of RNA polymerases. Nature Cell Biol. 7, 215-217 (2005).
87. Nakaya, K. et al. Identification of homozygous deletions of tumor suppressor gene FAT in oral cancer using CGH-array. Oncogene 26 Feb 2007 (doi:10.1038/sj.onc.1210330).
88. Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57-70 (2000).
89. Katoh, Y. & Katoh, M. Comparative integromics on FAT1, FAT2, FAT3 and FAT4. Int. J. Mol. Med. 18, 523-528 (2006).
90. Trofatter, J. A. et al. A novel moesin-, ezrin-, radixin-like gene is a candidate for the neurofibromatosis 2 tumor suppressor. Cell 72, 791-800 (1993).
91. Ruttledge, M. H. et al. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nature Genet. 6, 180-184 (1994).
92. Yoo, N. J. et al. Mutational analysis of salvador gene in human carcinomas. APMIS 111, 595-598 (2003).
93. St John, M. A. et al. Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction. Nature Genet. 21, 182-186 (1999).
94. Hisaoka, M., Tanaka, A. & Hashimoto, H. Molecular alterations of h-warts/LATS1 tumor suppressor in human soft tissue sarcoma. Lab. Invest. 82, 1427-1435 (2002).